United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded May 29, 2026 · Filed Jun 1, 2026

On May 29, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$553.83 for US$5.26M under a trading plan, leaving 40,513 shares. Filed Jun 1, 2026 (Form 4).

Sold
9,500 shares
Price
US$553.83 average (US$548.60 to US$559.41)
Value
US$5.26M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 29, 2026Common StockOption exercise9,500US$146.0350,013Direct
May 29, 2026Common StockSale280US$548.6049,733Direct
May 29, 2026Common StockSale769US$549.5948,964Direct
May 29, 2026Common StockSale1,605US$550.6047,359Direct
May 29, 2026Common StockSale986US$551.3446,373Direct
May 29, 2026Common StockSale680US$552.5845,693Direct
May 29, 2026Common StockSale823US$553.7344,870Direct
May 29, 2026Common StockSale817US$554.5744,053Direct
May 29, 2026Common StockSale1,000US$555.5943,053Direct
May 29, 2026Common StockSale461US$556.6742,592Direct
May 29, 2026Common StockSale918US$557.8041,674Direct
May 29, 2026Common StockSale841US$558.8140,833Direct
May 29, 2026Common StockSale320US$559.4140,513Direct

Source

View original at SEC

Related